Profile picture

Doctor Tomoyuki Nagai

Kyoto Prefectural University of Medicine, Kyoto (Japan)
Membership: ESC Professional Member
Follow
Logo ESC

Contributor content

Efficacy and safety of prolonged rivaroxaban treatment for high-bleeding risk cancer patients with acute low-risk pulmonary embolism: a post-hoc subgroup analysis of the ONCO PE trial
Presentation
Efficacy and safety of prolonged rivaroxaban treatment for high-bleeding risk cancer patients with acute low-risk pulmonary embolism: a post-hoc subgroup analysis of the ONCO PE trial
Read more
Efficacy and safety of long-term edoxaban treatment for low body weight cancer patients with isolated distal deep vein thrombosis: a post-hoc subgroup analysis of the ONCO DVT study
Presentation
Efficacy and safety of long-term edoxaban treatment for low body weight cancer patients with isolated distal deep vein thrombosis: a post-hoc subgroup analysis of the ONCO DVT study
Read more
Management of doxorubicin-induced cardiomyopathy as the adverse event of chemotherapy in acute critical decompensated heart failure: a case report.
Presentation
Management of doxorubicin-induced cardiomyopathy as the adverse event of chemotherapy in acute critical decompensated heart failure: a case report.
Read more

ESC 365 is supported by

novartis Explore sponsored resources